Global Biliary Tumor Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biliary Tumor Revenue
1.4 Market Analysis by Type
1.4.1 Global Biliary Tumor Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Mecine
1.4.3 Surgery
1.4.4 Other
1.5 Market by Application
1.5.1 Global Biliary Tumor Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Biliary Tumor Market Perspective (2015-2026)
2.2 Biliary Tumor Growth Trends by Regions
2.2.1 Biliary Tumor Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Biliary Tumor Historic Market Share by Regions (2015-2020)
2.2.3 Biliary Tumor Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Biliary Tumor Market Growth Strategy
2.3.6 Primary Interviews with Key Biliary Tumor Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Biliary Tumor Players by Market Size
3.1.1 Global Top Biliary Tumor Players by Revenue (2015-2020)
3.1.2 Global Biliary Tumor Revenue Market Share by Players (2015-2020)
3.1.3 Global Biliary Tumor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Biliary Tumor Market Concentration Ratio
3.2.1 Global Biliary Tumor Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Biliary Tumor Revenue in 2019
3.3 Biliary Tumor Key Players Head office and Area Served
3.4 Key Players Biliary Tumor Product Solution and Service
3.5 Date of Enter into Biliary Tumor Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Biliary Tumor Historic Market Size by Type (2015-2020)
4.2 Global Biliary Tumor Forecasted Market Size by Type (2021-2026)
5 Biliary Tumor Breakdown Data by Application (2015-2026)
5.1 Global Biliary Tumor Market Size by Application (2015-2020)
5.2 Global Biliary Tumor Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Biliary Tumor Market Size (2015-2020)
6.2 Biliary Tumor Key Players in North America (2019-2020)
6.3 North America Biliary Tumor Market Size by Type (2015-2020)
6.4 North America Biliary Tumor Market Size by Application (2015-2020)
7 Europe
7.1 Europe Biliary Tumor Market Size (2015-2020)
7.2 Biliary Tumor Key Players in Europe (2019-2020)
7.3 Europe Biliary Tumor Market Size by Type (2015-2020)
7.4 Europe Biliary Tumor Market Size by Application (2015-2020)
8 China
8.1 China Biliary Tumor Market Size (2015-2020)
8.2 Biliary Tumor Key Players in China (2019-2020)
8.3 China Biliary Tumor Market Size by Type (2015-2020)
8.4 China Biliary Tumor Market Size by Application (2015-2020)
9 Japan
9.1 Japan Biliary Tumor Market Size (2015-2020)
9.2 Biliary Tumor Key Players in Japan (2019-2020)
9.3 Japan Biliary Tumor Market Size by Type (2015-2020)
9.4 Japan Biliary Tumor Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Biliary Tumor Market Size (2015-2020)
10.2 Biliary Tumor Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Biliary Tumor Market Size by Type (2015-2020)
10.4 Southeast Asia Biliary Tumor Market Size by Application (2015-2020)
11 India
11.1 India Biliary Tumor Market Size (2015-2020)
11.2 Biliary Tumor Key Players in India (2019-2020)
11.3 India Biliary Tumor Market Size by Type (2015-2020)
11.4 India Biliary Tumor Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Biliary Tumor Market Size (2015-2020)
12.2 Biliary Tumor Key Players in Central & South America (2019-2020)
12.3 Central & South America Biliary Tumor Market Size by Type (2015-2020)
12.4 Central & South America Biliary Tumor Market Size by Application (2015-2020)
13Key Players Profiles
13.1 NuCana
13.1.1 NuCana Company Details
13.1.2 NuCana Business Overview and Its Total Revenue
13.1.3 NuCana Biliary Tumor Introduction
13.1.4 NuCana Revenue in Biliary Tumor Business (2015-2020))
13.1.5 NuCana Recent Development
13.2 NeoGenomics
13.2.1 NeoGenomics Company Details
13.2.2 NeoGenomics Business Overview and Its Total Revenue
13.2.3 NeoGenomics Biliary Tumor Introduction
13.2.4 NeoGenomics Revenue in Biliary Tumor Business (2015-2020)
13.2.5 NeoGenomics Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview and Its Total Revenue
13.3.3 Novartis Biliary Tumor Introduction
13.3.4 Novartis Revenue in Biliary Tumor Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 GlaxoSmithKline
13.4.1 GlaxoSmithKline Company Details
13.4.2 GlaxoSmithKline Business Overview and Its Total Revenue
13.4.3 GlaxoSmithKline Biliary Tumor Introduction
13.4.4 GlaxoSmithKline Revenue in Biliary Tumor Business (2015-2020)
13.4.5 GlaxoSmithKline Recent Development
13.5 Southwest Oncology Group
13.5.1 Southwest Oncology Group Company Details
13.5.2 Southwest Oncology Group Business Overview and Its Total Revenue
13.5.3 Southwest Oncology Group Biliary Tumor Introduction
13.5.4 Southwest Oncology Group Revenue in Biliary Tumor Business (2015-2020)
13.5.5 Southwest Oncology Group Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of TablesTable 1. Biliary Tumor Key Market Segments
Table 2. Key Players Covered: Ranking by Biliary Tumor Revenue
Table 3. Ranking of Global Top Biliary Tumor Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Biliary Tumor Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Mecine
Table 6. Key Players of Surgery
Table 7. Key Players of Other
Table 8. Global Biliary Tumor Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Biliary Tumor Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Biliary Tumor Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Biliary Tumor Market Share by Regions (2015-2020)
Table 12. Global Biliary Tumor Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Biliary Tumor Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Biliary Tumor Market Growth Strategy
Table 18. Main Points Interviewed from Key Biliary Tumor Players
Table 19. Global Biliary Tumor Revenue by Players (2015-2020) (Million US$)
Table 20. Global Biliary Tumor Market Share by Players (2015-2020)
Table 21. Global Top Biliary Tumor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biliary Tumor as of 2019)
Table 22. Global Biliary Tumor by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Biliary Tumor Product Solution and Service
Table 25. Date of Enter into Biliary Tumor Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Biliary Tumor Market Size by Type (2015-2020) (Million US$)
Table 28. Global Biliary Tumor Market Size Share by Type (2015-2020)
Table 29. Global Biliary Tumor Revenue Market Share by Type (2021-2026)
Table 30. Global Biliary Tumor Market Size Share by Application (2015-2020)
Table 31. Global Biliary Tumor Market Size by Application (2015-2020) (Million US$)
Table 32. Global Biliary Tumor Market Size Share by Application (2021-2026)
Table 33. North America Key Players Biliary Tumor Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Biliary Tumor Market Share (2019-2020)
Table 35. North America Biliary Tumor Market Size by Type (2015-2020) (Million US$)
Table 36. North America Biliary Tumor Market Share by Type (2015-2020)
Table 37. North America Biliary Tumor Market Size by Application (2015-2020) (Million US$)
Table 38. North America Biliary Tumor Market Share by Application (2015-2020)
Table 39. Europe Key Players Biliary Tumor Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Biliary Tumor Market Share (2019-2020)
Table 41. Europe Biliary Tumor Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Biliary Tumor Market Share by Type (2015-2020)
Table 43. Europe Biliary Tumor Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Biliary Tumor Market Share by Application (2015-2020)
Table 45. China Key Players Biliary Tumor Revenue (2019-2020) (Million US$)
Table 46. China Key Players Biliary Tumor Market Share (2019-2020)
Table 47. China Biliary Tumor Market Size by Type (2015-2020) (Million US$)
Table 48. China Biliary Tumor Market Share by Type (2015-2020)
Table 49. China Biliary Tumor Market Size by Application (2015-2020) (Million US$)
Table 50. China Biliary Tumor Market Share by Application (2015-2020)
Table 51. Japan Key Players Biliary Tumor Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Biliary Tumor Market Share (2019-2020)
Table 53. Japan Biliary Tumor Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Biliary Tumor Market Share by Type (2015-2020)
Table 55. Japan Biliary Tumor Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Biliary Tumor Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Biliary Tumor Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Biliary Tumor Market Share (2019-2020)
Table 59. Southeast Asia Biliary Tumor Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Biliary Tumor Market Share by Type (2015-2020)
Table 61. Southeast Asia Biliary Tumor Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Biliary Tumor Market Share by Application (2015-2020)
Table 63. India Key Players Biliary Tumor Revenue (2019-2020) (Million US$)
Table 64. India Key Players Biliary Tumor Market Share (2019-2020)
Table 65. India Biliary Tumor Market Size by Type (2015-2020) (Million US$)
Table 66. India Biliary Tumor Market Share by Type (2015-2020)
Table 67. India Biliary Tumor Market Size by Application (2015-2020) (Million US$)
Table 68. India Biliary Tumor Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Biliary Tumor Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Biliary Tumor Market Share (2019-2020)
Table 71. Central & South America Biliary Tumor Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Biliary Tumor Market Share by Type (2015-2020)
Table 73. Central & South America Biliary Tumor Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Biliary Tumor Market Share by Application (2015-2020)
Table 75. NuCana Company Details
Table 76. NuCana Business Overview
Table 77. NuCana Product
Table 78. NuCana Revenue in Biliary Tumor Business (2015-2020) (Million US$)
Table 79. NuCana Recent Development
Table 80. NeoGenomics Company Details
Table 81. NeoGenomics Business Overview
Table 82. NeoGenomics Product
Table 83. NeoGenomics Revenue in Biliary Tumor Business (2015-2020) (Million US$)
Table 84. NeoGenomics Recent Development
Table 85. Novartis Company Details
Table 86. Novartis Business Overview
Table 87. Novartis Product
Table 88. Novartis Revenue in Biliary Tumor Business (2015-2020) (Million US$)
Table 89. Novartis Recent Development
Table 90. GlaxoSmithKline Company Details
Table 91. GlaxoSmithKline Business Overview
Table 92. GlaxoSmithKline Product
Table 93. GlaxoSmithKline Revenue in Biliary Tumor Business (2015-2020) (Million US$)
Table 94. GlaxoSmithKline Recent Development
Table 95. Southwest Oncology Group Company Details
Table 96. Southwest Oncology Group Business Overview
Table 97. Southwest Oncology Group Product
Table 98. Southwest Oncology Group Revenue in Biliary Tumor Business (2015-2020) (Million US$)
Table 99. Southwest Oncology Group Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Biliary Tumor Market Share by Type: 2020 VS 2026
Figure 2. Mecine Features
Figure 3. Surgery Features
Figure 4. Other Features
Figure 5. Global Biliary Tumor Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Other Case Studies
Figure 9. Biliary Tumor Report Years Considered
Figure 10. Global Biliary Tumor Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Biliary Tumor Market Share by Regions: 2020 VS 2026
Figure 12. Global Biliary Tumor Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Biliary Tumor Market Share by Players in 2019
Figure 15. Global Top Biliary Tumor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biliary Tumor as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Biliary Tumor Revenue in 2019
Figure 17. North America Biliary Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Biliary Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Biliary Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Biliary Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Biliary Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Biliary Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Biliary Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. NuCana Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. NuCana Revenue Growth Rate in Biliary Tumor Business (2015-2020)
Figure 26. NeoGenomics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. NeoGenomics Revenue Growth Rate in Biliary Tumor Business (2015-2020)
Figure 28. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Novartis Revenue Growth Rate in Biliary Tumor Business (2015-2020)
Figure 30. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. GlaxoSmithKline Revenue Growth Rate in Biliary Tumor Business (2015-2020)
Figure 32. Southwest Oncology Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Southwest Oncology Group Revenue Growth Rate in Biliary Tumor Business (2015-2020)
Figure 34. Bottom-up and Top-down Approaches for This Report
Figure 35. Data Triangulation
Figure 36. Key Executives Interviewed